Please join our Virtual Reality Ending Aging Forum!
This event will showcase the newest breakthroughs in rejuvenation biotechnologies happening at the SENS Research Foundation’s Research Center in Mountain View, CA, as well as the research funded at extramural labs.
The Forum will be hosted virtually through Meetaverse, a state-of-the-art Virtual Reality platform.
You won't need to download any special software or wear a VR headset to walk around in your avatar, enjoy the scientific presentations and visit the student poster booths in the Conference Hall.
You will also be able to connect with our scientists, team members, and other guests, through one-on-one or group conversations, watch videos and animations placed in the Expo Room, and much more.
Join us September 21st and 22nd at 9 am -1 pm, Pacific Time for a fun and educational experience, and come ready to network and meet donors who support longevity science, activists, and like-minded people who care about a future free of age-related disease.
https://www.sens.org/endingagingforum-2023/
This event will showcase the newest breakthroughs in rejuvenation biotechnologies happening at the SENS Research Foundation’s Research Center in Mountain View, CA, as well as the research funded at extramural labs.
The Forum will be hosted virtually through Meetaverse, a state-of-the-art Virtual Reality platform.
You won't need to download any special software or wear a VR headset to walk around in your avatar, enjoy the scientific presentations and visit the student poster booths in the Conference Hall.
You will also be able to connect with our scientists, team members, and other guests, through one-on-one or group conversations, watch videos and animations placed in the Expo Room, and much more.
Join us September 21st and 22nd at 9 am -1 pm, Pacific Time for a fun and educational experience, and come ready to network and meet donors who support longevity science, activists, and like-minded people who care about a future free of age-related disease.
https://www.sens.org/endingagingforum-2023/
SENS Research Foundation
Ending Aging Forum 2023 - SENS Research Foundation
This virtual event is your opportunity to hear first-hand about the latest advances that our in-house researchers are making toward new rejuvenation biotechnologies, along with some of our young scientists-in-training and outside researchers whose research…
Hi, here are our latest posts on Medium. We would be glad to read your comments and thoughts.
https://medium.com/@teterin_71247/how-can-you-earn-while-checking-your-health-db4f0fe2dc2b
https://medium.com/@teterin_71247/do-you-know-how-to-live-long-137710e848ed
https://medium.com/@teterin_71247/how-to-prolong-life-with-ai-insights-928a316b1a61
https://medium.com/@teterin_71247/how-ai-models-are-transforming-evidence-based-predictions-1724f566f501
https://medium.com/@teterin_71247/how-can-you-earn-while-checking-your-health-db4f0fe2dc2b
https://medium.com/@teterin_71247/do-you-know-how-to-live-long-137710e848ed
https://medium.com/@teterin_71247/how-to-prolong-life-with-ai-insights-928a316b1a61
https://medium.com/@teterin_71247/how-ai-models-are-transforming-evidence-based-predictions-1724f566f501
Medium
How can you earn while checking your health?
Digital world had made so many ways to earn money. While sitting at one place people are earning millions of dollars. You may also fill…
👍1
Hey everyone. For APOE-ε4 carriers (especially homozygotes) and their physicians, note a potential breakthrough paper.
Background: homotaurine (tramiprosate) was trialed as an Alzheimer's drug, was looking good but failed to meet its Phase III endpoints. Then the data was re-analyzed, and a gene dose–dependent effect was seen: it helped APOE-ε4 carriers: heterozygotes a bit; homozygotes a lot. The assumption was that it was clearing amyloid, and APOE-ε4 carriers have more amyloid, hence the gene-dose effect. But a new paper – a brilliant piece of analytic chemistry – suggests that homotaurine is an apoE4 structure corrector, which, if true, would be a game changer: it could mean that all APOE-ε4–associated pathology would be reduced with a simple supplement. (Just need to figure out dosing.)
https://molecularneurodegeneration.biomedcentral.com/articles/10.1186/s13024-023-00620-9
Homotaurine seems to induce an apoE3-like conformation in apoE4.
Corrective gene therapy is the ultimate solution for APOE-ε4 carriers, but for now, taking this simple supplement (it's available without a prescription) could really help, especially for homozygotes. It appears to be very safe. (Some people experience nausea and even vomiting though.)
Alzheon has modified homotaurine to improve the PK and tolerability and is running trials in APOE-ε4 homozygotes. Provisional results have been announced and it looks good so far.
https://alzheon.com/alzheon-reports-industry-leading-biomarker-brain-preservation-and-clinical-benefits-following-24-months-of-treatment-in-phase-2-trial-of-oral-alz-801-valiltramiprosate-in-patients-with-early-alzhei/
https://alzheon.com/pipeline/alzheon-alz-801/
Alzheon will be presenting in Boston next month. I will try to go:
https://www.ctad-alzheimer.com/
Background: homotaurine (tramiprosate) was trialed as an Alzheimer's drug, was looking good but failed to meet its Phase III endpoints. Then the data was re-analyzed, and a gene dose–dependent effect was seen: it helped APOE-ε4 carriers: heterozygotes a bit; homozygotes a lot. The assumption was that it was clearing amyloid, and APOE-ε4 carriers have more amyloid, hence the gene-dose effect. But a new paper – a brilliant piece of analytic chemistry – suggests that homotaurine is an apoE4 structure corrector, which, if true, would be a game changer: it could mean that all APOE-ε4–associated pathology would be reduced with a simple supplement. (Just need to figure out dosing.)
https://molecularneurodegeneration.biomedcentral.com/articles/10.1186/s13024-023-00620-9
Homotaurine seems to induce an apoE3-like conformation in apoE4.
Corrective gene therapy is the ultimate solution for APOE-ε4 carriers, but for now, taking this simple supplement (it's available without a prescription) could really help, especially for homozygotes. It appears to be very safe. (Some people experience nausea and even vomiting though.)
Alzheon has modified homotaurine to improve the PK and tolerability and is running trials in APOE-ε4 homozygotes. Provisional results have been announced and it looks good so far.
https://alzheon.com/alzheon-reports-industry-leading-biomarker-brain-preservation-and-clinical-benefits-following-24-months-of-treatment-in-phase-2-trial-of-oral-alz-801-valiltramiprosate-in-patients-with-early-alzhei/
https://alzheon.com/pipeline/alzheon-alz-801/
Alzheon will be presenting in Boston next month. I will try to go:
https://www.ctad-alzheimer.com/
BioMed Central
Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer’s Disease drug candidate - Molecular …
Background Apolipoprotein E (ApoE) ε4 genotype is the most prevalent risk factor for late-onset Alzheimer’s Disease (AD). Although ApoE4 differs from its non-pathological ApoE3 isoform only by the C112R mutation, the molecular mechanism of its proteinopathy…
Cryotherapy Benefits
Decreases Muscle Soreness after exercise [1,2,3]
Helps Alleviate Chronic Pain - Especially in Rheumatic Arthritis and Fybromyalgia [6]
WBC mimics exercise, in its ability to induce a pulsatile expression of myokines (IL-6, irisin) opening possibilities for treating Obesity and Type 2 Diabetes - [2]
Metabolism up-regulation [2]
positive influence on inflammatory mediators, [2}
Increased antioxidant capacity, [2]
Improved autonomic nervous system function [2]
Does not blunt Exercise Effectiveness [4]
Improves depression [5]
^1 - https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008262.pub2/full
^2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411446/
^3 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956737/
^4 https://www.frontiersin.org/articles/10.3389/fspor.2022.834386/full
^5 https://www.sciencedirect.com/science/article/pii/S0965229921001242#bib29
^6 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119547/
Cold swimming benefits 0-5 C
Benefits - Lowers blood pressure
Decrease in triglycerides
Increase in insulin sensitivity
Decrease in norepinephrine
Increase in cortisol
Antidepressant effect
Immune system
Increase in leucocytes
Increase in monocytes
Fewer infections (40% lower Upper Resp Tract Infections)
Cold-Water Swimming Benefits and Risks
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730683/
Decreases Muscle Soreness after exercise [1,2,3]
Helps Alleviate Chronic Pain - Especially in Rheumatic Arthritis and Fybromyalgia [6]
WBC mimics exercise, in its ability to induce a pulsatile expression of myokines (IL-6, irisin) opening possibilities for treating Obesity and Type 2 Diabetes - [2]
Metabolism up-regulation [2]
positive influence on inflammatory mediators, [2}
Increased antioxidant capacity, [2]
Improved autonomic nervous system function [2]
Does not blunt Exercise Effectiveness [4]
Improves depression [5]
^1 - https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008262.pub2/full
^2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411446/
^3 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956737/
^4 https://www.frontiersin.org/articles/10.3389/fspor.2022.834386/full
^5 https://www.sciencedirect.com/science/article/pii/S0965229921001242#bib29
^6 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119547/
Cold swimming benefits 0-5 C
Benefits - Lowers blood pressure
Decrease in triglycerides
Increase in insulin sensitivity
Decrease in norepinephrine
Increase in cortisol
Antidepressant effect
Immune system
Increase in leucocytes
Increase in monocytes
Fewer infections (40% lower Upper Resp Tract Infections)
Cold-Water Swimming Benefits and Risks
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730683/
PubMed Central (PMC)
Whole-Body Cryotherapy in Athletes: From Therapy to Stimulation. An Updated Review of the Literature
Nowadays, whole-body cryotherapy is a medical physical treatment widely used in sports medicine. Recovery from injuries (e.g., trauma, overuse) and after-season recovery are the main purposes for application. However, the most recent studies confirmed ...
Longevity InTime: Anti-Aging Digital Health Immortality Transhumanist AI Channel
Hey everyone. For APOE-ε4 carriers (especially homozygotes) and their physicians, note a potential breakthrough paper. Background: homotaurine (tramiprosate) was trialed as an Alzheimer's drug, was looking good but failed to meet its Phase III endpoints.…
X (formerly Twitter)
Science Magazine (@ScienceMagazine) on X
Oral microbiota form distinct biofilms in different regions of the mouth that protect host tissues. When these biofilms become unbalanced, they may contribute to various diseases, including #Alzheimers.
Learn more: https://t.co/dinLXThfDA
Learn more: https://t.co/dinLXThfDA
Longevity InTime: Anti-Aging Digital Health Immortality Transhumanist AI Channel
Hey everyone. For APOE-ε4 carriers (especially homozygotes) and their physicians, note a potential breakthrough paper. Background: homotaurine (tramiprosate) was trialed as an Alzheimer's drug, was looking good but failed to meet its Phase III endpoints.…
MIT News
Decoding the complexity of Alzheimer’s disease
Using more than 2 million cells from over 400 postmortem brain samples, MIT researchers performed the largest-scale analysis of the genomic, epigenomic, and transcriptomic changes that occur in every cell type in the brains of Alzheimer’s patients.
Good afternoon!
My girlfriend has 2 relatives here in Dar es Salaam (Tanzania)
1. Older brother is 29 years old. From the age of 22 he began to suffer from some kind of mental disorder. I think it is autism
2. Cousin is 4 years old. His mother (the girl's sister) died during childbirth. And the boy most likely has cerebral palsy. But it is not exactly
Can you help find recommended specialists and centers to work with such people? Remotely from anywhere or/and in Africa / Tanzania?
The family did not have the opportunity to take care of the children's health, as it is common not only in Africa. I would like to help them
Thanks for any help and advice
My girlfriend has 2 relatives here in Dar es Salaam (Tanzania)
1. Older brother is 29 years old. From the age of 22 he began to suffer from some kind of mental disorder. I think it is autism
2. Cousin is 4 years old. His mother (the girl's sister) died during childbirth. And the boy most likely has cerebral palsy. But it is not exactly
Can you help find recommended specialists and centers to work with such people? Remotely from anywhere or/and in Africa / Tanzania?
The family did not have the opportunity to take care of the children's health, as it is common not only in Africa. I would like to help them
Thanks for any help and advice
We organized the first Rally for Longevity in Madrid.... working towards #TheDeathOfDeath, enjoy LIFE 🖖🖖🖖 https://youtu.be/2YW0jj00UMU
YouTube
Marcha por la Longevidad de Madrid 2023 • Día Internacional de la Longevidad • Versión resumen
¡La Marcha por la Longevidad fue todo un éxito!
1 de octubre, 2023 • Día de la Longevidad
11.00h - 13.00h • Madrid
Versión completa (47:47 min.) - https://youtu.be/pmfr9wrRJOk
Vídeo: Sergio Martínez de Lahidalga Tarrero
Cámaras: Sergio M.L. Tarrero, Íñigo…
1 de octubre, 2023 • Día de la Longevidad
11.00h - 13.00h • Madrid
Versión completa (47:47 min.) - https://youtu.be/pmfr9wrRJOk
Vídeo: Sergio Martínez de Lahidalga Tarrero
Cámaras: Sergio M.L. Tarrero, Íñigo…
❤1
https://www.businesswire.com/news/home/20231018615272/en/Physics-Powered-GenAI-Biotech-Gero-Raises-6M-to-Find-Root-Causes-of-Aging-and-Age-Related-Diseases
Team, our competitors doing fundraising on the same topics we are working on
Team, our competitors doing fundraising on the same topics we are working on
BusinessWire
Physics-Powered GenAI Biotech Gero Raises $6M to Find Root Causes of Aging and Age-Related Diseases
Gero, a biotechnology company focused on aging and chronic diseases, has closed a $6M Series A extension round.
❤3🔥1
Dr Church super optimistic and mentions BioViva https://www.youtube.com/watch?v=ON8vxUInQYA
YouTube
Affordable Gene Therapies Are Coming! - George Church at EARD
In this talk, Dr. George Church discusses the current advancements in affordable gene and cell therapies aimed at age-related diseases, including their potential for significantly improving health outcomes. It includes a discussion about advancements in genomic…